Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: A randomized controlled trial

Aim: To compare clomiphene citrate (CC), metformin or the combination of CC and metformin as the first line ovulation induction drug in Asian Indian women with polycystic ovary syndrome (PCOS). Methods: One hundred and five newly diagnosed, treatment naive PCOS women were recruited. They were random...

Full description

Saved in:
Bibliographic Details
Main Authors: Sujata Kar (Author), Smriti Sanchita (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2015-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_6b8b42d9f6ee46ee859c304814a1cbbd
042 |a dc 
100 1 0 |a Sujata Kar  |e author 
700 1 0 |a Smriti Sanchita  |e author 
245 0 0 |a Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: A randomized controlled trial 
260 |b Wolters Kluwer Medknow Publications,   |c 2015-01-01T00:00:00Z. 
500 |a 0974-1208 
500 |a 1998-4766 
500 |a 10.4103/0974-1208.170373 
520 |a Aim: To compare clomiphene citrate (CC), metformin or the combination of CC and metformin as the first line ovulation induction drug in Asian Indian women with polycystic ovary syndrome (PCOS). Methods: One hundred and five newly diagnosed, treatment naive PCOS women were recruited. They were randomized into any of the three groups: Group I (CC 50-150 mg/day), Group II (metformin 1700 mg/day), and Group III (CC + metformin in similar dosage to Groups I and II). Patients underwent follicular monitoring and advice on timed intercourse. The study period was 6 months, or till pregnant, or till CC resistant. Primary outcome studied was live birth rate (LBR). Secondary outcomes were ovulation rate, pregnancy rate, and early pregnancy loss rate. Results: There was no significant difference among the groups in baseline characteristics and biochemical parameters. LBR was 41.6%, 37.5%, and 28.1%, respectively in Groups III, II, and I. Group III (CC + metformin) had the highest ovulation (83.3%), pregnancy (50%), and LBRs (41.6%). Group II (metformin) was as good as Group I (CC) in all the outcomes. CC + metformin (Group III) had statistically significantly higher ovulation rate as compared to CC alone (Group I) (P = 0.03; odds ratio: 95% confidence interval: 3.888 [1.08-13.997]). Conclusion: Thus, our study shows that metformin was as good as CC in terms of "LBR" and the combination of CC and metformin gave the highest ovulation and LBR. 
546 |a EN 
690 |a Clomiphene citrate 
690 |a metformin 
690 |a ovulation induction 
690 |a polycystic ovary syndrome 
690 |a pregnancy rate 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n Journal of Human Reproductive Sciences, Vol 8, Iss 4, Pp 197-201 (2015) 
787 0 |n http://www.jhrsonline.org/article.asp?issn=0974-1208;year=2015;volume=8;issue=4;spage=197;epage=201;aulast=Kar 
787 0 |n https://doaj.org/toc/0974-1208 
787 0 |n https://doaj.org/toc/1998-4766 
856 4 1 |u https://doaj.org/article/6b8b42d9f6ee46ee859c304814a1cbbd  |z Connect to this object online.